Characteristic patterns of complement deposition in NMOSD, MOGAD, and MS

The complement system is involved in the pathogenesis of inflammatory demyelinating diseases (IDDs) of the CNS. While complement inhibition significantly reduces the relapse rate in neuromyelitis optica spectrum disorders (NMOSDs), no clear consensus has been reached regarding the role of complement in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and multiple sclerosis (MS). Therefore, we examined CNS tissues from patients with NMOSD (18 autopsies and one biopsy, median age: 56 years), MOGAD (seven autopsies and 20 biopsies, median age: 34 years) and MS (24 autopsies, median age: 54.5 years) to assess the involvement of the complement system from a histopathological perspective. To investigate complement activity at multiple steps, the tissue deposition of three different complement components (C4d, C3d, and C9neo) was examined using immunohistochemistry. In NMOSD, the typical perivascular rosette/rim pattern of complement deposition was confirmed by the three different complement products within acute astrocyte-lytic lesions. In MOGAD, we observed C4d deposition around perivenous demyelinating lesions in 83% (20/24 tissues). However, C9neo deposition differed between patients, with 73% (11/15 patients with perivenous demyelination-predominant MOGAD) showing limited deposition of C9neo with relatively well-preserved oligodendrocytes (MOGAD type A), while 27% showing strong deposition accompanied by the disappearance of oligodendrocytes (MOGAD type B). The more destructive type B pathology was more frequent among deceased than living patients who, by contrast, had type A pathology in the vast majority. In MS, only C4d showed clear deposits on myelin sheaths in the peri-plaque white matter bordering the edges of the demyelinating lesions. These findings seemed to be characteristic of MS, and the extent and intensity tended to decrease in accordance with lesion activity. Complement deposition in MS lesions was linked to shorter interval between onset and death. These characteristic patterns of complement deposition in the three IDDs likely reflect the distinct pathogeneses of the diseases.

Authors

Institutions

Publication Details

Journal
Acta Neuropathologica
Published
2026-02-09
DOI
https://doi.org/10.1007/s00401-026-02985-9
Citations
1
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
36.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Characteristic patterns of complement deposition in NMOSD, MOGAD, and MS

Tatsuro Misu, K. Fujihara, Masashi Watanabe, Takashi Suzuki et al.
1 citations
Acta Neuropathologica
Multiple Sclerosis Research Studies
36.00
article

Characteristic patterns of complement deposition in NMOSD, MOGAD, and MS

Tatsuro Misu, K. Fujihara, Masashi Watanabe, Takashi Suzuki, Masashi Aoki, Yasushi Iwasaki, Stephan Bramow, Monika Bradl, Romana Höftberger, Christian J. Riedl, Hiroaki Miyahara, Hans P. Lassmann, Guy Laureys, Franziska Di Pauli, Sara Mariotto, Mari Yoshida, Toshiyuki Takahashi, Simon Hametner, Yoshiki Takai, Brenda Banwell
article en
1 citations

Abstract

The complement system is involved in the pathogenesis of inflammatory demyelinating diseases (IDDs) of the CNS. While complement inhibition significantly reduces the relapse rate in neuromyelitis optica spectrum disorders (NMOSDs), no clear consensus has been reached regarding the role of complement in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and multiple sclerosis (MS). Therefore, we examined CNS tissues from patients with NMOSD (18 autopsies and one biopsy, median age: 56 years), MOGAD (seven autopsies and 20 biopsies, median age: 34 years) and MS (24 autopsies, median age: 54.5 years) to assess the involvement of the complement system from a histopathological perspective. To investigate complement activity at multiple steps, the tissue deposition of three different complement components (C4d, C3d, and C9neo) was examined using immunohistochemistry. In NMOSD, the typical perivascular rosette/rim pattern of complement deposition was confirmed by the three different complement products within acute astrocyte-lytic lesions. In MOGAD, we observed C4d deposition around perivenous demyelinating lesions in 83% (20/24 tissues). However, C9neo deposition differed between patients, with 73% (11/15 patients with perivenous demyelination-predominant MOGAD) showing limited deposition of C9neo with relatively well-preserved oligodendrocytes (MOGAD type A), while 27% showing strong deposition accompanied by the disappearance of oligodendrocytes (MOGAD type B). The more destructive type B pathology was more frequent among deceased than living patients who, by contrast, had type A pathology in the vast majority. In MS, only C4d showed clear deposits on myelin sheaths in the peri-plaque white matter bordering the edges of the demyelinating lesions. These findings seemed to be characteristic of MS, and the extent and intensity tended to decrease in accordance with lesion activity. Complement deposition in MS lesions was linked to shorter interval between onset and death. These characteristic patterns of complement deposition in the three IDDs likely reflect the distinct pathogeneses of the diseases.

Acta NeuropathologicaVol. 151(1)
University of Verona (IT), Fukushima Medical University (JP), Innsbruck Medical University (AT), Johns Hopkins University (US), Aichi Medical University (JP), Universität Innsbruck (AT), Tohoku University (JP), Ghent University Hospital (BE), Comprehensive Cancer Center Vienna (AT), Tohoku University Hospital (JP), National Hospital Organization (JP), Danish Multiple Sclerosis Center (DK), Ehime Prefectural Central Hospital (JP), Tochigi Medical Center (JP), Kobe University (JP), Medical University of Vienna (AT)
Ministry of Education, Culture, Sports, Science and Technology, Austrian Science Fund, Ministry of Health, Labour and Welfare, Österreichische Forschungsförderungsgesellschaft, National Institutes of Health, Japan Society for the Promotion of Science
Good health and well-being
Openalex Percentile: Top 1%
Multiple Sclerosis Research Studies
36.00
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.